Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|8|643-671

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.8, 2003-03, pp. : 643-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders

By Lees G.J.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 33-78

Adis International

Access to resources Recommend Favorite

-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders

By Hayashi T.   Su T-P.  

CNS Drugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 269-284

Adis International

Access to resources Recommend Favorite

AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3536-3565

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders

By Gold B.G.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2331-2342

Informa Healthcare

Access to resources Recommend Favorite